Page last updated: 2024-10-25

ciglitazone and Cholestasis, Intrahepatic

ciglitazone has been researched along with Cholestasis, Intrahepatic in 1 studies

ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.

Cholestasis, Intrahepatic: Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Snow, KL1
Moseley, RH1

Other Studies

1 other study available for ciglitazone and Cholestasis, Intrahepatic

ArticleYear
Effect of thiazolidinediones on bile acid transport in rat liver.
    Life sciences, 2007, Jan-30, Volume: 80, Issue:8

    Topics: Animals; Bile Acids and Salts; Bile Canaliculi; Biological Transport; Cell Membrane; Cholestasis, In

2007